Skip to main content
. 2022 Jan 5;11:780655. doi: 10.3389/fonc.2021.780655

Figure 1.

Figure 1

KRAS function and its main downstream pathways. This diagram is a summary of KRAS oncogenic mutations that impair its activity to hydrolyze GTP, thereby activating three major signaling pathways that mediate basic cellular processes. KRAS, kirsten rat sarcoma viral oncogene homolog; Gh2, growth hormone 2; SOS, Son of Sevenless; GTP, guanosine triphosphate; GDP, guanosine diphosphate; GAPs, GTPase-activating proteins; PI3K, phosphoinositide 3-kinase; Akt/PKB, protein kinase B; BAD, BCL-2/BCL-XL-associated death promoter; CASP9, Recombinant Caspase 9; PIP3, phosphatidyl inositol triphosphate; PDK1, 3-phosphoinositide dependent kinase-1; RASSF1, Ras association domain family 1; MST1, human macrophage stimulation 1; Raf, rat fibrosarcoma; MEK, mitogen-activated protein kinase kinase; ERK, extracellular regulated kinase; NORE1A, Ras-association domain family 5.